A methyl jasmonate derivative, J-7, induces apoptosis in human hepatocarcinoma Hep3B cells in vitro

Toxicology in Vitro

Volumn 24, Issue 7, 2010, Pages 1920-1926

  Park, Cheol ^a   Jin, Cheng Yun ^a   Kim, Gi Young ^b   Cheong, JaeHun ^c   Jung, Jee H ^c   Yoo, Young Hyun ^d   Choi, Yung Hyun ^a,e  

^a Dong Eui University   (South Korea)

^b Jeju National University   (South Korea)

^c Pusan National University   (South Korea)

^d Dong A University College of Medicine   (South Korea)

^e Dong Eui University   (South Korea)

Author keywords

Apoptosis; Hep3B; MAPK; Methyl jasmonate derivative

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; [METHYL 5 CHLORO 4,5 DIDEHYDROJASMONATE[7]]; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 3 INHIBITOR; CASPASE 8; CASPASE 9; DEATH RECEPTOR 5; J 7; JASMONIC ACID METHYL ESTER; METHYL JASMONATE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; STRESS ACTIVATED PROTEIN KINASE; TRYPAN BLUE; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL ASSAY; CELL LINE; CELL STRAIN HEPB3 CELL; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME DEGRADATION; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; MITOCHONDRION; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASES; CELL LINE, TUMOR; CYCLOPENTANES; DNA FRAGMENTATION; FATTY ACIDS, UNSATURATED; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION;

EID: 77957018959     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.08.001     Document Type: Article

References (36)

1. Aggarwal B.B., Bhardwaj U., Takada Y. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors. Vitamins & Hormones 2004, 67:453-483.
2. Carr B.I. Hepatocellular carcinoma: current management and future trends. Gastroenterology 2004, 127:218-224.
3. Chopra P., Kanoje V., Semwal A., Ray A. Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases. Expert Opinion on Investigational Drugs 2008, 17:1411-1425.
4. Cohen S., Flescher E. Methyl jasmonate: a plant stress hormone as an anti-cancer drug. Phytochemistry 2009, 70:1600-1609.
5. Coleman W.B. Mechanisms of human hepatocarcinogenesis. Current Molecular Medicine 2003, 3:573-588.
6. Cuevas B.D., Abell A.N., Johnson G.L. Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 2007, 26:3159-3171.
7. Dang H.T., Lee H.J., Yoo E.S., Hong J., Bao B., Choi J.S., Jung J.H. New jasmonate analogues as potential anti-inflammatory agents. Bioorganic & Medicinal Chemistry 2008, 16:10228-10235.
8. Dangl J.L., Dietrich R.A., Richberg M.H. Death don't have no mercy: cell death programs in plant-microbe interactions. Plant Cell 1996, 8:1793-1807.
9. Earnshaw W.C., Martins L.M., Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annual Review of Biochemistry 1999, 68:383-424.
10. Farmer E.E., Ryan C.A. Interplant communication: air-borne methyl jasmonate induces synthesis of proteinase inhibitors in plant leaves. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:7713-7716.
11. Fingrut O., Flescher E. Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells. Leukemia 2002, 16:608-616.
12. Fingrut O., Reischer D., Rotem R., Goldin N., Altboum I., Zan-Bar I., Flescher E. Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells. British Journal of Pharmacology 2005, 146:800-808.
13. Flescher E. Jasmonates - a new family of anti-cancer agents. Anticancer Drugs 2005, 16:911-916.
14. Ghobrial I.M., Witzig T.E., Adjei A.A. Targeting apoptosis pathways in cancer therapy. CA: A Cancer Journal for Clinicians 2005, 55:178-194.
15. Han S.I., Kim Y.S., Kim T.H. Role of apoptotic and necrotic cell death under physiologic conditions. BMB Reports 2008, 41:1-10.
16. Hill C.S., Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 1995, 80:199-211.
17. Ichijo H. From receptors to stress-activated MAP kinases. Oncogene 1999, 18:6087-6093.
18. Im J.H., Kim S.J. Paclitaxel induced caspase-independent mitotic catastrophe in rabbit articular chondrocyte. Journal of Life Science 2010, 20:519-527.
19. Ince N., Wands J.R. The increasing incidence of hepatocellular carcinoma. The New England Journal of Medicine 1999, 340:798-799.
20. Jang K.J., Han M.H., Lee B.H., Kim B.W., Kim C.H., Yoon H.M., Choi Y.H. Induction of apoptosis by ethanol extracts of Ganoderma lucidum in human gastric carcinoma cells. The Journal of Acupuncture and Meridian Studies 2010, 3:24-31.
21. Jeong S.Y., Seol D.W. The role of mitochondria in apoptosis. BMB Reports 2008, 41:11-22.
22. Jung J.U., Ko K., Lee D.H., Ko K., Chang K.T., Choo Y.K. The roles of glycosphingolipids in the proliferation and neural differentiation of mouse embryonic stem cells. Experimental & Molecular Medicine 2009, 41:935-945.
23. Kniazhanski T., Jackman A., Heyfets A., Gonen P., Flescher E., Sherman L. Methyl jasmonate induces cell death with mixed characteristics of apoptosis and necrosis in cervical cancer cells. Cancer Letters 2008, 271:34-46.
24. Lau W.Y., Lai E.C. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary & Pancreatic Diseases International 2008, 7:237-257.
25. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371:346-347.
26. Makin G., Dive C. Apoptosis and cancer chemotherapy. Trends in Cell Biology 2001, 11:S22-26.
27. Marotta F., Vangieri B., Cecere A., Gattoni A. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect. La Clinica Terapeutica 2004, 155:187-199.
28. Mitler R., Lam E. Sacrifice in the face of foes: pathogen-induced programmed cell death in higher plants. Trends in Microbiology 1996, 4:10-15.
29. Nagata S., Golstein P. The Fas death factor. Science 1995, 267:1449-1456.
30. Ofer K., Gold D., Flescher E. Methyl jasmonate induces cell cycle block and cell death in the amitochondriate parasite Trichomonas vaginalis. International Journal for Parasitology 2008, 38:959-968.
31. Okuda K. Hepatocellular carcinoma. Journal of Hepatology 2000, 32:S225-237.
32. Reischer D., Heyfets A., Shimony S., Nordenberg J., Kashman Y., Flescher E. Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma. British Journal of Pharmacology 2007, 150:738-749.
33. Rotem R., Fingrut O., Moskovitz J., Flescher E. The anticancer agent methyl jasmonate induces activation of stress-regulated c-Jun N-terminal kinase and p38 protein kinase in human lymphoid cells. Leukemia 2003, 17:2230-2234.
34. Rotem R., Heyfets A., Fingrut O., Blikckstein D., Shaklai M., Flescher E. Jasmonates: novel anti-cancer agents acting directly and selectively on human cancer cell mitochondria. Cancer Research 2005, 65:1984-1993.
35. Weber H. Fatty acid-derived signals in plants. Trends in Plant Science 2002, 7:217-224.
36. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270:1326-1331.